profiles.mountsinai.org Open in urlscan Pro
2600:141b:1c00:2584::179b  Public Scan

Form analysis
0 forms found in the DOM

Text Content

=
Search
 * 1-800-MD-SINAI
 * MyMountSinai® (MyChart)
 * Pay My Bill

 * 1-800-MD-SINAI
 * Find a Doctor
 * Request an Appointment
 * Our Locations
 * Patient Care
 * About Us
   Search

 * Home
   
 * Profiles
 * 

Mount Sinai Doctors?


PANAGIOTIS ROUSSOS, MD, MS, PHD


PSYCHIATRY

No Patient Experience Ratings
Why not?
 * About Me
 * Education & Certifications
 * Awards
 * Research
 * Insurance
 * Publications
 * Industry Relationships


ABOUT ME

Panos Roussos is a Professor of Psychiatry and Genetics and Genomic Sciences, a
member of the Friedman Brain Institute and the Director of the Center for
Disease Neurogenomics at the Icahn School of Medicine at Mount Sinai. He is also
a VA/MIRECC Research Physician at the James J. Peters VA Medical Center.

Panos Roussos received his medical and doctorate degrees from the University of
Crete in Greece. He completed his residency in Psychiatry (research track) at
Icahn School of Medicine at Mount Sinai followed by a MIRECC research fellowship
in schizophrenia.



 

LANGUAGE

English

POSITION

PROFESSOR | Genetics and Genomic Sciences, PROFESSOR | Psychiatry, PROFESSOR |
Artificial Intelligence and Human Health

HOSPITAL AFFILIATIONS

 * Mount Sinai Queens
 * The Mount Sinai Hospital

RESEARCH TOPICS

Alzheimer's Disease, Bioinformatics, Brain, Cerebral Cortex, Chromatin,
Computational Biology, Epigenetics, Gene Expressions, Gene Regulation, Genetics,
Genomics, Microarray, Neurobiology, Neuroscience, Prefrontal Cortex,
Schizophrenia, Systems Biology

MULTI-DISCIPLINARY TRAINING AREAS

Genetics and Genomic Sciences [GGS], Neuroscience [NEU]

Show More


ABOUT ME

Panos Roussos is a Professor of Psychiatry and Genetics and Genomic Sciences, a
member of the Friedman Brain Institute and the Director of the Center for
Disease Neurogenomics at the Icahn School of Medicine at Mount Sinai. He is also
a VA/MIRECC Research Physician at the James J. Peters VA Medical Center.

Panos Roussos received his medical and doctorate degrees from the University of
Crete in Greece. He completed his residency in Psychiatry (research track) at
Icahn School of Medicine at Mount Sinai followed by a MIRECC research fellowship
in schizophrenia.



 

LANGUAGE

English

POSITION

PROFESSOR | Genetics and Genomic Sciences, PROFESSOR | Psychiatry, PROFESSOR |
Artificial Intelligence and Human Health

HOSPITAL AFFILIATIONS

 * Mount Sinai Queens
 * The Mount Sinai Hospital

RESEARCH TOPICS

Alzheimer's Disease, Bioinformatics, Brain, Cerebral Cortex, Chromatin,
Computational Biology, Epigenetics, Gene Expressions, Gene Regulation, Genetics,
Genomics, Microarray, Neurobiology, Neuroscience, Prefrontal Cortex,
Schizophrenia, Systems Biology

MULTI-DISCIPLINARY TRAINING AREAS

Genetics and Genomic Sciences [GGS], Neuroscience [NEU]


EDUCATION

MD, UNIVERSITY OF CRETE

MD, UNIVERSITY OF CRETE

MS, UNIVERSITY OF CRETE

PHD, UNIVERSITY OF CRETE

RESIDENCY, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

RESIDENCY, PSYCHIATRY

Mount Sinai Hospital


AWARDS

2020

Eva King Killam Research Award

American College of Neuropsychopharmacology

2019

Scientific Award in Life Sciences (Biomedical Sciences)

Bodossakis Foundation

2019

Rising Star Award, Rising Star Award

Congress of the Schizophrenia International Research Society

2016

Presidential Early Career Awards for Scientists and Engineers

White House

2013

Young Investor Award

NARSAD

2012

Early Academic Career Award

APA/Merck

2010

Outstanding Resident Award

National Institute of Mental Health


RESEARCH

Panos Roussos's research is focused on precision psychiatry by identifying the
genetic variants and underlying mechanisms that cause disease and, ultimately,
enabling personalized therapy.

Visit our website: https://icahn.mssm.edu/research/neurogenomics/ and
https://labs.icahn.mssm.edu/roussos-lab/


INSURANCE INFORMATION

Physicians who provide services at hospitals and facilities in the Mount Sinai
Health System might not participate in the same health plans as those Mount
Sinai hospitals and facilities (even if the physicians are employed or
contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may
be found on this page, and can also be obtained by contacting this provider
directly. Because physicians insurance participation can change, the insurance
information on this page may not always be up-to-date. Please contact this
physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System
hospitals and facilities participate in can be found on the Mount Sinai Health
System website.


PUBLICATIONS

Publications:237

SELECTED PUBLICATIONS

 * Analysis of microisolated frontal cortex excitatory layer III and V pyramidal
   neurons reveals a neurodegenerative phenotype in individuals with Down
   syndrome. Melissa J. Alldred, Harshitha Pidikiti, Kyrillos W. Ibrahim, Sang
   Han Lee, Adriana Heguy, Gabriel E. Hoffman, Panos Roussos, Thomas Wisniewski,
   Jerzy Wegiel, Grace E. Stutzmann, Elliott J. Mufson, Stephen D. Ginsberg.
   Acta Neuropathologica
 * Correction to: Divergent landscapes of A-to-I editing in postmortem and
   living human brain (Nature Communications, (2024), 15, 1, (5366),
   10.1038/s41467-024-49268-z). Miguel Rodriguez de los Santos, Brian H. Kopell,
   Ariela Buxbaum Grice, Gauri Ganesh, Andy Yang, Pardis Amini, Lora E.
   Liharska, Eric Vornholt, John F. Fullard, Pengfei Dong, Eric Park, Sarah
   Zipkowitz, Deepak A. Kaji, Ryan C. Thompson, Donjing Liu, You Jeong Park,
   Esther Cheng, Kimia Ziafat, Emily Moya, Brian Fennessy, Lillian Wilkins,
   Hannah Silk, Lisa M. Linares, Brendan Sullivan, Vanessa Cohen, Prashant Kota,
   Claudia Feng, Jessica S. Johnson, Marysia Kolbe Rieder, Joseph Scarpa, Girish
   N. Nadkarni, Minghui Wang, Bin Zhang, Pamela Sklar, Noam D. Beckmann, Eric E.
   Schadt, Panos Roussos, Alexander W. Charney, Michael S. Breen. Nature
   Communications
 * Distinct genetic liability profiles define clinically relevant patient strata
   across common diseases. Lucia Trastulla, Georgii Dolgalev, Sylvain Moser,
   Laura T. Jiménez-Barrón, Till F.M. Andlauer, Moritz von Scheidt, Douglas M.
   Ruderfer, Stephan Ripke, Andrew McQuillin, Eli A. Stahl, Enrico Domenici,
   Rolf Adolfsson, Ingrid Agartz, Esben Agerbo, Margot Albus, Madeline
   Alexander, Farooq Amin, Silviu A. Bacanu, Martin Begemann, Richard A.
   Belliveau, Judit Bene, Sarah E. Bergen, Elizabeth Bevilacqua, Tim B. Bigdeli,
   Donald W. Black, Douglas H.R. Blackwood, Anders D. Borglum, Elvira Bramon,
   Richard Bruggeman, Nancy G. Buccola, Randy L. Buckner, Brendan
   Bulik-Sullivan, Joseph D. Buxbaum, William Byerley, Wiepke Cahn, Guiqing Cai,
   Dominique Campion, Rita M. Cantor, Vaughan J. Carr, Noa Carrera, Stanley V.
   Catts, David Cohen, Kenneth L. Davis, Elodie Drapeau, Joseph I. Friedman,
   Vahram Haroutunian, René S. Kahn, Abraham Reichenberg, Panos Roussos, Jeremy
   M. Silverman. Nature Communications

View All Publications


INDUSTRY RELATIONSHIPS

Physicians and scientists on the faculty of the Icahn School of Medicine at
Mount Sinai often interact with pharmaceutical, device, biotechnology companies,
and other outside entities to improve patient care, develop new therapies and
achieve scientific breakthroughs. In order to promote an ethical and transparent
environment for conducting research, providing clinical care and teaching, Mount
Sinai requires that salaried faculty inform the School of their outside
financial relationships.

Dr. Roussos has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry
are posted on our website. Patients may wish to ask their physician about the
activities they perform for companies.

Show More

Physicians and scientists on the faculty of the Icahn School of Medicine at
Mount Sinai often interact with pharmaceutical, device, biotechnology companies,
and other outside entities to improve patient care, develop new therapies and
achieve scientific breakthroughs. In order to promote an ethical and transparent
environment for conducting research, providing clinical care and teaching, Mount
Sinai requires that salaried faculty inform the School of their outside
financial relationships.

Dr. Roussos has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry
are posted on our website. Patients may wish to ask their physician about the
activities they perform for companies.

 * 
 * 
 * 
 * 
 * 
 * 
 * 

 * COVID-19 Staff Resources
 * 1-800-MD-SINAI1-800-MD-SINAI

 * Patient Information
 * Find a Doctor
 * Pay My Bill
 * International Services
 * Mount Sinai Access
 * Patient Representatives Offices
 * Language and Accessibility
 * Health Library
 * Clinical Trials

 * Research & Education
 * Icahn School of Medicine at Mount Sinai
 * Medical Education
 * Graduate Education
 * Research
 * Find Faculty
 * Phillips School of Nursing

 * Stay Connected
 * MyMountSinai® Mobile App
 * MyChart Desktop site
 * Newsroom
 * Mount Sinai Today Blog

 * For Health Professionals
 * Transfer a Patient
 * Mount Sinai Connect
 * Refer a Patient
 * Nursing
 * Hospital Sponsored Programs
 * Medical Staff Services

©2024 Icahn School of Medicine at Mount Sinai
 * Contact Us
 * Careers
 * Terms & Conditions
 * Privacy Policy
 * HIPAA Privacy Practices
 * Compliance

 * Non-Discrimination Notice
 * Patient Responsibilities
 * Insurance Information
 * Vendors